Wiley Matthew T.insider trades

In SEC Form 4 filings, Wiley Matthew T. is listed as Chief Commercial Officer of Definium Therapeutics, Inc. (DFTX). In the last 90 days, Wiley Matthew T. sold $113.3K of Definium Therapeutics, Inc. (DFTX) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
DFTXDefinium Therapeutics, Inc.	Chief Commercial Officer	2	Sep 29

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-14

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
DFTXDefinium Therapeutics, Inc.	Sep 25	Sep 29	S	3,097	$36.57	Sale −$113,257	359,036	Yes	Form 4
DFTXDefinium Therapeutics, Inc.	Sep 14	Sep 14	A	125,000	$0.00	$0	362,133	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.